Agilent profits surge; Cromsource offers new early-stage ops; New manufacturing plant opens in China;

> Stronger sales of Agilent Technologies' testing and measurement equipment pushed first-quarter profits up 19%. Story

> Cromsource has joined forces with a state-owned clinical research operation in Italy to offer new early-stage facilities for its clients. Story

> China's Asymchem Laboratories cut the ribbon on a new large-scale manufacturing facility in Dunhua, P.R. China. Release

> Clinipace Worldwide has hired Dr. Jurgen Frisch as its chief medical officer for European operations. Report

> China CRO Sundia MediTech Company announced that Dr. Xiaochuan Wang has resigned as chairman of the board due to health reasons. Release

> Inviragen and Advanced BioScience Laboratories inked a contract manufacturing deal. More

Suggested Articles

The coronavirus is now putting a strain on CROs and researchers in affected areas.

Synteract has boosted its reach into the Asia-Pacific region and South Africa after snapping up a specialty biometrics CRO.

It’s a tale as old as time: Drug development can be a slow, expensive and laborious task and, more often than not, yields failure.